Group files complaint to B.C. Human Rights Tribunal to remove drug clinic access fees
A complaint has been filed with B.C.'s Human Rights Tribunal over clinic fees being charged to some British Columbians accessing opioid treatments.
Vancouver lawyer Jason Gratl said his clients, drug policy advocate Garth Mullins and the B.C. Association for People on Opioid Maintenance, have filed the complaint on behalf of those "who paid out-of-pocket private clinic access fees" for opioid agonist treatments.
Gratl said the current system requires patients to pay private clinic access fees ranging from $60 to $100 per month in order to receive advice or prescriptions from a practitioner who's enrolled in the Medical Services Plan.
He said in a release that the model "targets" drug users "on the basis of discriminatory attitudes and stereotypes" and violates provincial law that expressly prohibits the fees where publicly funded health services are provided.
The complaint calls for an end to the current access fee model and for the province to pay those fees under the public health-care system.
Gratl said his clients also want the province to reimburse the fees already paid by members of the class covered in the complaint, all of whom have opioid use disorder.
The complaint says opioid use disorder is recognized as a disability under B.C.'s Human Rights Code.
"This funding model impedes access to medical treatment for persons seeking to control and stabilize their substance use disorders," Gratl said in the release.
"Requiring patients to pay out-of-pocket clinic fee[s] discriminates against persons with substance use disorder[s] who attempt to seek medical treatment."
The B.C. Health Ministry did not immediately respond to a request for comment.
The complaint dated Feb. 25 says Mullins, a Vancouver-based podcast host and activist, is the director of the association and a "person receiving opioid maintenance treatment."
"[Opioid agonist treatment] is a medical treatment necessary to treat a medical condition and disability," the complaint says.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
14 hours ago
- CTV News
Study examines hockey players' brains during games
Vancouver Watch A new study is shedding light on differences in brain activity between hockey players in various positions.
CTV News
19 hours ago
- CTV News
40 artificial intelligence programs underway at Fraser Health, but executives are mum
In this still from a YouTube video, Sheazin Premji, bottom right, the executive director of Fraser Health's Centre for Advanced Analytics, Data Science and Innovation (CAADSI), speaks on a panel hosted by Simon Fraser University's Digital Innovation and Leadership program. Fraser Health is aggressively pursuing artificial intelligence programs with at least 40 initiatives underway, but the health authority refuses to make any officials available to discuss whether the investments represent good value for taxpayer money or are essentially pet projects following a trend. CTV News has obtained documents Fraser Health has presented to outside stakeholders outlining their plans to harness technology with the goal of improving efficiency and services in B.C.'s most populous health authority. Despite numerous requests over two months, communications staff claimed no one was available to discuss them at any time, even weeks in advance. The health authority has publicly announced the rollout of a handful of AI-powered strategies, including predicting patient discharge dates and a system to pre-determine staffing requirements. The latter is particularly eyebrow-raising as a priority, considering the staffing needs are already well-known and numerous health officials have acknowledged they simply do not have enough personnel for the volume of patients in our rapidly growing province. In a presentation on Fraser Health's 'Digital Twin' program at Digital Health Canada last year, senior officials outlined a system with theoretical scenarios and virtual patients that recreates the health authority digitally in order to 'test and understand the impact on bottlenecks and inform decision-making before deploy(ing) in (the) real world.' This initiative and its use to the public health-care system, if any, has not been discussed with patients or taxpayers. How deep is Fraser Health in the AI space? In another presentation at Digital Health Canada, Sheazin Premji, the executive director of Fraser Health's Centre for Advanced Analytics, Data Science and Innovation (CAADSI) included a slide stating the health authority has '40+ AI solutions across three streams, in varying stages of development and deployment.' Fraser Health AI Fraser Health has more than 40 AI programs, according to this slide from a presentation by one of its leading technology officers. The same slide says Fraser Health has in-house, co-created and licensed software. Another slide lays out a future envisioning medical drones, facial recognition technology, 3D bioprinting, robot companions and portable diagnostic devices. Hospital and ICU mortality, ethnicity prediction, pediatric respiratory triaging, chatbots and patient information summarizers are current AI projects in progress, according to the presentation, with various companies providing services in addition to the in-house systems. Are these programs worth millions of tax dollars? Several health authorities in the province are adopting AI technology, and family doctors are also embracing time-saving scribes to summarize appointments and cut down on time spent doing paperwork. Fraser Health insists it's in full compliance with Canada's privacy laws and points to its 'mandatory Privacy Impact Assessments, Security Threat and Risk Assessments, AI Risk Assessments for AI solutions, and our corporate policy on Responsible use of Generative Artificial Intelligence in the Workplace.' However, neither its website nor a vague written statement sent to CTV News make any mention of how the programs are evaluated for success or value for precious tax dollars. 'Is that the place where it's needed most?' asked Kim McGrail, a professor at UBC's School of Population and Public Health and Centre for Health Services and Policy Research, and scientific director of Population Data BC and Health Data Research Network Canada. She said while there have been detailed studies and analysis of programs in other provinces, we need to see more in B.C. She was unsurprised to learn CTV News had been unsuccessful in discussing artificial intelligence initiatives with Fraser Health. 'I think what you're pointing out is sort of a general lack of transparency in our health system,' said McGrail. 'There's a lot of things we don't know or understand, either about decision-making or about inputs or about outcomes, and in health care, we could know more and we could report more publicly than we do now, so AI is perhaps another example of that.' In a discussion with Simon Fraser University's Digital Innovation and Leadership program posted to YouTube, Premji told the moderators that 'we do need to look at that value, of the AI, and I think we need to do a better job on showing the (return on investment).' This is the third part in a CTV Vancouver series taking a deep dive into the use of artificial intelligence in health care. You can read part one here: Eye contact and earlier diagnosis: How AI is transforming front-line health care in B.C. And part two here: B.C.'s privacy watchdog weighs in on health AI boom – as doctors warn it's not a substitute
Globe and Mail
19 hours ago
- Globe and Mail
BioGrowing Shines at Probiota Americas 2025, Leading Innovation in Probiotic Applications for Oral and Weight Management
VANCOUVER - June 13, 2025 - BioGrowing, the Diamond Sponsor of Probiota Americas 2025, showcased groundbreaking advancements in oral health and weight management at the event. Through keynote presentations and panel discussions, the Chinese probiotic leader demonstrated its cutting-edge capabilities to the global scientific community. Innovative Oral Probiotic Solution Targets Billion-Dollar Market Dr. Zhanxi Hao, Vice President of the BioGrowing Research Institute, delivered a inspiring speech titled "Innovations In Oral Probiotics Research And Market Trends." He highlighted the rapid growth of the global oral healthcare market, projected to exceed $700 billion USD by 2030, with China's oral probiotic segment showing equally strong momentum. Probiotics, as core modulators of the oral microbiome, are driving oral health products to become a major market force due to their proven efficacy. As a pioneer in China's probiotic industry, BioGrowing has achieved technological leadership in oral probiotics through years of strain development: Lacticaseibacillus paracasei LPc-G110: The clinical research validating these oral probiotic strains was conducted at the Academic Centre for Dentistry Amsterdam (ACTA), ranked No. 1 in Europe and No. 2 globally in the QS World University Rankings for Dentistry. The trials demonstrated that BioGrowing's oral probiotic formulations effectively: Improve gingivitis, Reduce dental plaque formation, Decrease levels of harmful oral bacteria, Enhance oral micro-ecological stability. Ligilactobacillus salivarius LS-G60: Addresses halitosis at its source by inhibiting volatile sulfur compound (VSC) production. Clinically proven to outperform conventional treatments in combating halitosis. The Flora-Focus® Oral Health Fomula , developed based on these innovations, is now in industrial application. Concurrently launched, the novel OralBubble™ Probiotic Microbubble Lozenges deliver 10 Billion CFU per piece of clinically validated strains, offering a one-stop solution for 8 major oral concerns and meeting on-the-go oral health needs. Finished product testing confirms that the probiotic bubble tablets achieve VSC (volatile sulfur compound) inhibition rates of 98.76% at 16 hours and 98.09% at 24 hours post-administration, clinically validating their efficacy in delivering 24-hour oral freshness and halitosis reduction. Triple-Strain Consortium Addresses Global Obesity Challenge During the "Probiotics And Weight Management: Science or Myth?" roundtable discussion, BioGrowing's experts presented the company's latest research findings and scientific evidence supporting probiotic efficacy in weight management, exploring practical applications and potential in this field. Highlighting the public health crisis – global obesity rates surged from 36% (2000) towards 50% (2023) per the World Obesity Atlas 2025, with China designating 2025 as its "Weight Management Year" – BioGrowing introduced the Flora-Focus® Weight Management Fomula: Features a targeted triple-strain consortium: Lactobacillus gasseri LG-G12, Lactiplantibacillus plantarum ZJUF T17, and Lactiplantibacillus plantarum ZJUF T34. Mechanism: Enhances lipid metabolism efficiency, increases beige adipose tissue content, and inhibits high-fat diet-induced weight gain, while reducing hyperlipidemia risks associated with obesity. Provides a precise weight management solution for individuals with frequent dietary indiscretions, weight management goals, or dyslipidemia. Expanding Health Frontiers Through Scientific Rigor "From oral microbiome modulation to metabolic management, we are systematically building comprehensive probiotic health solutions," emphasized Dr. Hao. BioGrowing's relevant products have already secured international orders, marking the global reach of China's microbial technology innovation. Moving forward, BioGrowing remains committed to expanding health frontiers, delivering science-backed, safe, and effective health solutions to consumers worldwide. Media Contact Company Name: BIOGROWING CO.,LTD. Contact Person: Echo Sun Email: Send Email Country: China Website:
